Relationship between the Activities of Daily Living Questionnaire and the Montreal Cognitive Assessment

Durant, January; Léger, Gabriel C.; Banks, Sarah J.; Miller, Justin B.

doi:10.1016/j.dadm.2016.06.001

Cited by 26 publications

(21 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many studies have utilized MoCA for assessing cognitive function related to the patient's functional impairment [ 17 18 ]. Schweizer et al [ 30 ] reported that MoCA was more sensitive than MMSE in detecting cognitive impairment after hemorrhagic stroke.…”

Section: Discussionmentioning

confidence: 99%

“…However, existing studies on MoCA and functional outcome were mostly performed on elderly patients with heterogeneous diseases and mild functional impairment. Durant et al [ 17 ] found that lower a MoCA score was associated with greater functional impairment in neurodegenerative diseases, including Alzheimer disease, mild cognitive impairment, cognitive disorder, Lewy body dementia, vascular dementia, etc. However, these studies had the limitation of being a heterogeneous clinical sample, focusing on current function rather than the recovery of the patient's function.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Correlation Between Montreal Cognitive Assessment and Functional Outcome in Subacute Stroke Patients With Cognitive Dysfunction

et al. 2018

View full text Add to dashboard Cite

ObjectiveTo investigate the correlation between the Montreal Cognitive Assessment (MoCA) and functional outcome among subacute stroke patients with cognitive dysfunction.MethodsRecords of 61 inpatients were reviewed. Patients were divided into two groups based on their initial MoCA score. MoCA score of 11 was set as the differentiating criterion. We compared the improvements in Modified Barthel Index (MBI) from initial assessment to discharge between the two groups.ResultsThere were no significant differences between the two groups in relation to age, duration from onset to admission, hospitalization period, or years of education. In a comparison of the results of Mini-Mental Status Examinations (MMSE) administered at admission and again at discharge, there was significantly more improvement in MMSE scores in the group with low MoCA scores than in the group with high MoCA scores. However, the group with high MoCA scores also showed high MBI scores at discharge and exhibited greater MBI improvement.ConclusionHigher initial MoCA scores (which reflect preservation of executive function) indicate better functional outcome in the subacute stroke phase.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Correlation Between Montreal Cognitive Assessment and Functional Outcome in Subacute Stroke Patients With Cognitive Dysfunction

et al. 2018

View full text Add to dashboard Cite

show abstract

“… 27 , 28 MoCA scores have also been shown to correlate with the Activities of Daily Living Questionnaire 29 a measure of functional integrity in dementia. 30 The MoCA has the further advantage of yielding not only a total score (overall measure) but also index scores based on individual items tapping domains of attention, retentive memory, orientation, language, and executive function. 31 …”

Section: Methodsmentioning

confidence: 99%

Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS)

Weıntraub

Besser

Dodge

et al. 2018

Alzheimer Disease &Amp; Associated Disorders

400

410

View full text Add to dashboard Cite

Introduction:The neuropsychological battery of the Uniform Data Set (UDSNB) was implemented in 2005 by the National Institute on Aging (NIA) Alzheimer Disease Centers program to measure cognitive performance in dementia and mild cognitive impairment due to Alzheimer Disease. This paper describes a revision, the UDSNB 3.0.Methods:The Neuropsychology Work Group of the NIA Clinical Task Force recommended revisions through a process of due diligence to address shortcomings of the original battery. The UDSNB 3.0 covers episodic memory, processing speed, executive function, language, and constructional ability. Data from 3602 cognitively normal participants in the National Alzheimer Coordinating Center database were analyzed.Results:Descriptive statistics are presented. Multivariable linear regression analyses demonstrated score differences by age, sex, and education and were also used to create a normative calculator available online.Discussion:The UDSNB 3.0 neuropsychological battery provides a valuable non proprietary resource for conducting research on cognitive aging and dementia.

show abstract

“…Their physical status, major vascular risk factors [22], and neurological syndromes were assessed. The severity of cognitive impairment was determined concurrently using the Montreal Cognitive Assessment (MoCA) scale and independence in everyday life [23]. Dementia was diagnosed if the MoCA score was <26 points and the patient was dependent on others; cognitive impairment was considered mild if the score was <26 points and the patient was independent.…”

Section: Methodsmentioning

confidence: 99%

Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease

et al. 2019

View full text Add to dashboard Cite

Cerebral small vessel disease (SVD) is one of the leading causes of cognitive impairment and stroke. The importance of endothelial dysfunction and high blood–brain barrier (BBB) permeability in pathogenesis, together with ischemia, is under discussion. The aim of this study was to clarify the relationship between tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1), and magnetic resonance imaging (MRI) signs of SVD. We examined 71 patients (23 men and 48 women; mean age: 60.5 ± 6.9 years) with clinical and MRI signs of SVD, and 21 healthy volunteers with normal MRIs. All subjects underwent 3T MRI and measurements of t-PA and PAI-1 levels. An increase in t-PA level is correlated with the volume of white matter hyperintensities (WMH) (R = 0.289, p = 0.034), severity on the Fazekas scale (p = 0.000), and with the size of subcortical (p = 0.002) and semiovale (p = 0.008) perivascular spaces. The PAI-1 level is not correlated with the t-PA level or MRI signs of SVD. The correlation between t-PA and the degree of WMH and perivascular spaces’ enlargement, without a correlation with PAI-1 and lacunes, is consistent with the importance of t-PA in BBB disruption and its role in causing brain damage in SVD.

show abstract

Relationship between the Activities of Daily Living Questionnaire and the Montreal Cognitive Assessment

Cited by 26 publications

References 16 publications

Correlation Between Montreal Cognitive Assessment and Functional Outcome in Subacute Stroke Patients With Cognitive Dysfunction

Correlation Between Montreal Cognitive Assessment and Functional Outcome in Subacute Stroke Patients With Cognitive Dysfunction

Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS)

Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease

Contact Info

Product

Resources

About